Targeted hepatitis C antibody testing interventions
暂无分享,去创建一个
M. Hellard | Y. Falck‐Ytter | S. Hutchinson | Bryce D. Smith | S. Wiktor | M. Stoové | R. Morgan | S. Corson | J. Doyle | D. Goldberg | E. Aspinall | D. Hunt | Tim Nguyen | Y. Falck-Ytter | David Hunt
[1] J. McVeigh,et al. Effectiveness of interventions to increase hepatitis C testing uptake among high-risk groups: a systematic review. , 2014, European journal of public health.
[2] Iris R. Mabry-Hernandez,et al. Screening for hepatitis C virus infection. , 2012, Gastroenterology & hepatology.
[3] M. Sweat,et al. Provider-Initiated HIV Testing and Counseling in Low- and Middle-Income Countries: A Systematic Review , 2013, AIDS and Behavior.
[4] Graham Cooke,et al. Chronic hepatitis C treatment outcomes in low- and middle-income countries: a systematic review and meta-analysis. , 2012, Bulletin of the World Health Organization.
[5] C. Christiansen,et al. Primary care-based interventions are associated with increases in hepatitis C virus testing for patients at risk. , 2012, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[6] G. Foster,et al. 903 WHAT IS THE BEST METHOD OF CASE FINDING FOR CHRONIC VIRAL HEPATITIS IN AT-RISK MIGRANT COMMUNITIES? , 2012 .
[7] S. Hutchinson,et al. Identifying former injecting drug users infected with hepatitis C: an evaluation of a general practice-based case-finding intervention. , 2012, Journal of public health.
[8] J. Ward,et al. The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings , 2012, Annals of Internal Medicine.
[9] P. Hayes,et al. Excess liver‐related morbidity of chronic hepatitis C patients, who achieve a sustained viral response, and are discharged from care , 2011, Hepatology.
[10] G. Dore,et al. What Is Killing People with Hepatitis C Virus Infection? , 2011, Seminars in liver disease.
[11] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[12] Louisa Degenhardt,et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews , 2011, The Lancet.
[13] P. Vanhems,et al. A randomized trial of viral hepatitis prevention among underprivileged people in the Lyon area of France. , 2011, Journal of public health.
[14] N. D. de Wit,et al. Cost-effectiveness of targeted screening for hepatitis C in The Netherlands , 2011, Epidemiology and Infection.
[15] Robert C Hornik,et al. Use of mass media campaigns to change health behaviour , 2010, The Lancet.
[16] N. D. de Wit,et al. A support programme for primary care leads to substantial improvements in the effectiveness of a public hepatitis C campaign. , 2010, Family practice.
[17] M. Volk,et al. A sustained viral response is associated with reduced liver-related morbidity and mortality in patients with hepatitis C virus. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[18] S. Hutchinson,et al. Evaluation of a General Practice Based Hepatitis C Virus Screening Intervention , 2009, Scottish medical journal.
[19] D. Lavanchy,et al. The global burden of hepatitis C , 2009, Liver international : official journal of the International Association for the Study of the Liver.
[20] G. Defossez,et al. Evaluation of the French national plan to promote screening and early management of viral hepatitis C, between 1997 and 2003: a comparative cross-sectional study in Poitou-Charentes region , 2008, European journal of gastroenterology & hepatology.
[21] G. Guyatt,et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations , 2008, BMJ : British Medical Journal.
[22] T. Nichols,et al. Increasing the uptake of hepatitis C virus testing among injecting drug users in specialist drug treatment and prison settings by using dried blood spots for diagnostic testing: a cluster randomized controlled trial , 2008, Journal of viral hepatitis.
[23] B. Conway,et al. Barriers associated with the treatment of hepatitis C virus infection among illicit drug users. , 2008, Drug and alcohol dependence.
[24] A. Mijch,et al. Hepatitis C in Psychiatry Inpatients: Testing Rates, Prevalence and Risk Behaviours , 2007, Australasian psychiatry : bulletin of Royal Australian and New Zealand College of Psychiatrists.
[25] B. Conway,et al. Factors associated with spontaneous clearance of hepatitis C virus among illicit drug users. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.
[26] Anne M Johnson,et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours , 2007, AIDS.
[27] A. Staines,et al. Hepatitis C infection among injecting drug users in general practice: a cluster randomised controlled trial of clinical guidelines' implementation. , 2006, The British journal of general practice : the journal of the Royal College of General Practitioners.
[28] B. Bell,et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.
[29] U Siebert,et al. The cost-effectiveness of testing for hepatitis C in former injecting drug users. , 2006, Health technology assessment.
[30] M. Alter,et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. , 2005, The Journal of infectious diseases.
[31] Colin W Shepard,et al. Global epidemiology of hepatitis C virus infection. , 2005, The Lancet. Infectious diseases.
[32] C. Trépo,et al. Hepatitis C screening practices among private practitioners: impact of an information campaign. , 2004, Gastroenterologie clinique et biologique.
[33] G. Defossez,et al. [Epidemiology and management of care of hepatitis C infection in the Poitou-Charentes region in 1997 and 2000]. , 2003, Gastroenterologie clinique et biologique.
[34] F. Roudot-thoraval,et al. [Strategies of hepatitis C screening in general practice. Results of a two-center randomized trial]. , 2000, Gastroenterologie clinique et biologique.
[35] D. Vlahov,et al. Incidence and risk factors for hepatitis C among injection drug users in Baltimore, Maryland , 1997, Journal of clinical microbiology.
[36] H. Margolis,et al. Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection. , 1990, JAMA.
[37] S. Zeuzem,et al. EASL Clinical Practice Guidelines: management of hepatitis C virus infection. , 2014, Journal of hepatology.
[38] Y. Shaobin,et al. AASLD PRACTICE GUIDELINES:diagnosis,management,and treatment of hepatitis C:an update , 2009 .